Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sunshine Biopharma Equity Warrant Exp 15 Feb 2027 SBFMW

Healthcare Biotechnology
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has over 32 additional generic prescription drugs. In addition, the Company is conducting a proprietary drug development program which consists of K1.1 mRNA, an mRNA-Lipid Nanoparticle... see more

Recent & Breaking News (NDAQ:SBFMW)

Sunshine Biopharma Moves Principal Office to New York City

GlobeNewswire December 4, 2023

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

GlobeNewswire August 11, 2023

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

GlobeNewswire May 16, 2023

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

GlobeNewswire May 12, 2023

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

GlobeNewswire May 11, 2023

Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update

GlobeNewswire April 5, 2023

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment

GlobeNewswire February 28, 2023

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound

GlobeNewswire February 10, 2023

Sunshine Biopharma Announces Share Repurchase Program

GlobeNewswire January 19, 2023

Sunshine Biopharma's Annual Letter to Shareholders

GlobeNewswire December 20, 2022

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project

GlobeNewswire November 16, 2022

Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue

GlobeNewswire October 20, 2022

Sunshine Biopharma Files Its Second Quarter Report With the SEC

GlobeNewswire August 4, 2022

Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona

GlobeNewswire July 28, 2022

Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market

GlobeNewswire April 28, 2022

Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market

GlobeNewswire April 26, 2022

Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells

GlobeNewswire April 25, 2022

Sunshine Biopharma's Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells

GlobeNewswire April 5, 2022

Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-Market

GlobeNewswire March 14, 2022

Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market

GlobeNewswire March 10, 2022